NCT01453907View on ClinicalTrials.gov

Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

December 31, 2012

Conditions
Anthrax
Interventions
DRUG

"ETI-204, Anthim"

intravenously, single dose

DRUG

placebo

intravenously, single dose

Trial Locations (1)

66211

Quintiles, Overland Park

Sponsors
All Listed Sponsors
lead

Elusys Therapeutics

OTHER

NCT01453907 - Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers | Biotech Hunter | Biotech Hunter